Spero Therapeutics Inc (SPRO)
0.92
-0.04
(-4.14%)
USD |
NASDAQ |
Dec 23, 14:15
Spero Therapeutics Cash from Operations (TTM): -17.54M for Sept. 30, 2024
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| CytomX Therapeutics Inc | -88.29M |
| Castle Biosciences Inc | 59.09M |
| Arbutus Biopharma Corp | -71.83M |
| PTC Therapeutics Inc | -177.97M |
| Equillium Inc | -21.39M |